(Q43737173)

26 November 2017

Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit (English)

1 reference

26 November 2017

1 reference

1 reference

1 reference

Jennifer K Chow

1

1 reference

26 November 2017

Yoav Golan

2

1 reference

26 November 2017

Robin Ruthazer

3

1 reference

26 November 2017

Adolf W Karchmer

4

1 reference

26 November 2017

Yehuda Carmeli

5

1 reference

26 November 2017

Deborah Lichtenberg

6

1 reference

26 November 2017

Varun Chawla

7

1 reference

26 November 2017

Janet Young

8

1 reference

26 November 2017

Susan Hadley

9

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

Clinical Infectious Diseases

26 November 2017

1 reference

26 November 2017

46

1 reference

26 November 2017

1206-1213

1 reference

26 November 2017

8

1 reference

National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathog

26 November 2017

1 reference

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

21 January 2018

1 reference

Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study.

21 January 2018

1 reference

Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital

21 January 2018

1 reference

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

21 January 2018

1 reference

The epidemiology of candidemia in two United States cities: results of a population-based active surveillance

21 January 2018

1 reference

Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital

21 January 2018

1 reference

Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period

21 January 2018

1 reference

Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.

21 January 2018

1 reference

A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

21 January 2018

1 reference

Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program

21 January 2018

1 reference

Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.

21 January 2018

1 reference

Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures

21 January 2018

1 reference

Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures

21 January 2018

1 reference

Epidemiology of Candida species infections in critically ill non-immunosuppressed patients

21 January 2018

1 reference

The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer

21 January 2018

1 reference

Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003.

21 January 2018

1 reference

Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study

21 January 2018

1 reference

Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital

21 January 2018

1 reference

Candida glabrata fungemia: experience in a tertiary care center

21 January 2018

1 reference

Temporal assessment of Candida risk factors in the surgical intensive care unit

21 January 2018

1 reference

Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients

21 January 2018

1 reference

Epidemiology of invasive candidiasis: a persistent public health problem

21 January 2018

1 reference

Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources

21 January 2018

1 reference

Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection

21 January 2018

1 reference

In vitro susceptibility of breakthrough Candida bloodstream isolates correlates with daily and cumulative doses of fluconazole

21 January 2018

1 reference

Risk factors for breakthrough candidemia

21 January 2018

1 reference

Importance of Candida species other than C. albicans as pathogens in oncology patients

21 January 2018

1 reference

Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance

21 January 2018

1 reference

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

21 January 2018

1 reference

Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death

21 January 2018

1 reference

Revisiting the Source of Candidemia: Skin or Gut?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/529435

1 reference

26 November 2017

1 reference